Modalités de prescription des inhibiteurs de la phospodiestérase de type 5 = Phosphodiesterase type 5 inhibitors: modalities of prescriptionDELAVIERRE, Dominique.Andrologie (Lille). 2004, Vol 14, Num 2, pp 239-241, issn 1166-2654, 3 p.Article

Single step isolation of sildenafil from commercially available Viagra tabletsFRANCIS, S. H; RAJA SEKHAR, K; ROUSE, A. B et al.International journal of impotence research. 2003, Vol 15, Num 5, pp 369-372, issn 0955-9930, 4 p.Article

Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation surveyKIM, N. N.International journal of impotence research. 2003, Vol 15, pp S13-S19, issn 0955-9930, SUP5Conference Paper

Changes in peak systolic velocity induced by chronic therapy with phosphodiesterase type-5 inhibitorSIGHINOLFI, M. C; MOFFERDIN, A; DE STEFANI, S et al.Andrologia. 2006, Vol 38, Num 3, pp 84-86, issn 0303-4569, 3 p.Article

Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse eventsBISCHOFF, E.International journal of impotence research. 2004, Vol 16, pp S34-S37, issn 0955-9930, SUP1Article

Phosphodiesterase 5 inhibitors in the treatment of premature ejaculationWANG, W. F; MINHAS, S; RALPH, D. J et al.International journal of andrology (Print). 2006, Vol 29, Num 5, pp 503-509, issn 0105-6263, 7 p.Article

Oxidative stress and antioxidant therapy: Their impact in diabetes-associated erectile dysfunctionDE YOUNG, Ling; YU, Darryl; BATEMAN, Ryon M et al.Journal of andrology. 2004, Vol 25, Num 5, pp 830-836, issn 0196-3635, 7 p.Article

The therapeutic dilemma : how to use short-acting PDE5 inhibitor drugsFABBRI, A; AVERSA, A.International journal of andrology. Supplement. 2005, Vol 28, Num 2, pp 69-73, issn 0106-1607, 5 p.Conference Paper

Peripheral regulatory mechanisms in erectionMORELLI, A; FILIPPI, S; ZHANG, X.-H et al.International journal of andrology. Supplement. 2005, Vol 28, Num 2, pp 23-27, issn 0106-1607, 5 p.Conference Paper

Implications of PDE4 structure on inhibitor selectivity across PDE familiesKE, H.International journal of impotence research. 2004, Vol 16, pp S24-S27, issn 0955-9930, SUP1Article

Why humans need type 5 phosphodiesterase inhibitorsCELLERINO, A; JANNINI, E. A.International journal of andrology. Supplement. 2005, Vol 28, Num 2, pp 14-17, issn 0106-1607, 4 p.Conference Paper

Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5COTE, R. H.International journal of impotence research. 2004, Vol 16, pp S28-S33, issn 0955-9930, SUP1Article

Dose-response relationship between testosterone and erectile function : Evidence for the existence of a critical thresholdARMAGAN, Abdullah; KIM, Noel N; GOLDSTEIN, Irwin et al.Journal of andrology. 2006, Vol 27, Num 4, pp 517-526, issn 0196-3635, 10 p.Article

Potency, selectivity, and consequences of nonselectivity of PDE inhibitionBISCHOFF, E.International journal of impotence research. 2004, Vol 16, pp S11-S14, issn 0955-9930, SUP1Article

Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetesGOOK JUN AHN; JAE YOUNG YU; SEUL MIN CHOI et al.International journal of andrology (Print). 2005, Vol 28, Num 5, pp 260-266, issn 0105-6263, 7 p.Article

The synergism of penile venous surgery and oral sildenafil in treating patients with erectile dysfunctionWEN, Hsien-Sheng; HSIEH, Cheng-Hsing; HSU, Geng-Long et al.International journal of andrology (Print). 2005, Vol 28, Num 5, pp 297-303, issn 0105-6263, 7 p.Article

Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive ratsWILKES, N; WHITE, S; STEIN, P et al.International journal of impotence research. 2004, Vol 16, Num 2, pp 187-194, issn 0955-9930, 8 p.Article

Oral phosphodiesterase-5 inhibitors : effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissueABDEL AZIZ, M. T; MOSTAFA, T; ATTA, H et al.Andrologia. 2007, Vol 39, Num 2, pp 66-70, issn 0303-4569, 5 p.Article